特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
949612

プロトンポンプ阻害剤(PPI)市場(2020年~2026年)

Proton Pump Inhibitors (PPI) Market 2020-2026

出版日: | 発行: Orion Market Research Pvt Ltd | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.59円
プロトンポンプ阻害剤(PPI)市場(2020年~2026年)
出版日: 2020年06月18日
発行: Orion Market Research Pvt Ltd
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のプロトンポンプ阻害剤市場は、予測期間中に大幅に成長すると推定されています。市場の成長を促進する主な要因には、ジュース、食品などの酸性摂取物が食道に移行する際、消化の問題が発生することが含まれます。GERD(胃食道逆流症)はすべての年齢層の人々に影響を及ぼし、喘息患者はGERDを発症するリスクが高くなります。さらに、消化性潰瘍の数の増加、胃酸の問題、および新規送達システムの需要の増加により、市場の成長が加速しています。

世界のプロトンポンプ阻害剤市場は種類と医薬品タイプに基づいて分割されます。種類別では、市場はエソメプラゾール、オメプラゾール、デキスランソプラゾール、パントプラゾール、ラベプラゾール、ランソプラゾール、その他に分類されます。医薬品タイプ別では、市場はOTC(市販薬)と処方箋に分類されます。Pfizer は、エソメプラゾール薬物の消費量の増加により、フランス、ドイツ、イタリアなどの欧州諸国のほとんどでNexiumをOTC製品として推奨しました。地理的には、 世界のプロトンポンプ阻害剤市場は、 北米 、欧州、アジア太平洋、その他の世界の地域に分割されます。消化器系の問題の数の増加と新製品の継続的な生産により、市場は加速しています。

PPIを提供している主要企業には、AstraZeneca PLC、Takeda Pharmaceuticals Co. Ltd.、Pfizer, Inc.、Bayer AG、Janssen Pharmaceutical, Inc. (Johnson & Johnson Service Inc.の一部)、Aurobindo Pharma, Ltd.、Eisai Co., Ltd.、Procter & Gamble Co.、またSanofi S.A.があります。これらのプレーヤーは、市場での競争力を維持し、 市場シェアを拡大するために、さまざまな戦略を採用しています。

当レポートでは世界のプロトンポンプ阻害剤(PPI)市場を調査し、市場の概要、市場の成長要因および阻害要因の分析、種類・医薬品タイプ・地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイル、市場機会など、体系的な情報を提供しています。

目次

第1章 レポートの概要

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
  • 規則と規制

第3章 競合情勢

  • 会社シェア分析
  • 主要戦略分析
  • 主要企業分析
    • AstraZeneca PLC
    • Takeda Pharmaceuticals Co. Ltd.
    • Pfizer, Inc.
    • Bayer AG
    • Janssen Pharmaceutical, Inc. (Johnson&Johnson Service Inc.の一部)

第4章 市場決定要因

  • 動機
  • 抑制要因
  • 市場機会

第5章 市場セグメンテーション

  • 種類別
    • エソメプラゾール
    • オメプラゾール
    • デキスランソプラゾール
    • パントプラゾール
    • ラベプラゾール
    • ランソプラゾール
    • その他
  • 医薬品タイプ別
    • 市販薬
    • 処方箋

第6章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • その他アジア太平洋地域
  • その他の地域

第7章 企業プロファイル

  • Alkem Laboratories, Ltd.
  • AstraZeneca PLC
  • Aurobindo Pharma, Ltd.
  • Bayer AG
  • Cadila Healthcare, Ltd.
  • Chongqing LUMMY Pharmaceutical Co., Ltd.
  • Eisai Co., Ltd.
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals, Inc.
  • Janssen Pharmaceutical, Inc. (A Part ofJohnson & Johnson Service Inc.)
  • Lannett Company, Inc.
  • Novartis AG
  • Pfizer, Inc.
  • Procter & Gamble Co.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries, Ltd.
  • Takeda Pharmaceutical Co. Ltd.
  • Teva Pharmaceuticals Industries, Ltd.
図表

LIST OF TABLES

  • 1. GLOBAL PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 2. GLOBAL ESOMEPRAZOLEMARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 3. GLOBAL OMEPRAZOLE MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 4. GLOBAL DEXLANSOPRAZOLEMARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 5. GLOBAL PANTOPRAZOLE MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 6. GLOBAL RABEPRAZOLE MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 7. GLOBAL LANSOPRAZOLE MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 8. GLOBAL OTHER PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 9. GLOBAL PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY ADMINISTRATION, 2019-2026 ($ MILLION)
  • 10. GLOBAL OVER THE COUNTER PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 11. GLOBAL PRESCRIPTIONPROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 12. GLOBAL PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2019-2026 ($ MILLION)
  • 13. NORTH AMERICAN PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 14. NORTH AMERICAN PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 15. NORTH AMERICAN PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY ADMINISTRATION, 2019-2026 ($ MILLION)
  • 16. EUROPEAN PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 17. EUROPEAN PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 18. EUROPEAN PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY ADMINISTRATION, 2019-2026 ($ MILLION)
  • 19. ASIA-PACIFIC PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 20. ASIA-PACIFIC PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 21. ASIA-PACIFIC PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY ADMINISTRATION, 2019-2026 ($ MILLION)
  • 22. REST OF THE WORLD PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 23. REST OF THE WORLD PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BYADMINISTRATION, 2019-2026 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL PROTON PUMP INHIBITORS MARKET SHARE BY TYPE, 2019VS 2026 (%)
  • 2. GLOBAL PROTON PUMP INHIBITORS MARKET SHARE BY ADMINISTRATION, 2019VS 2026 (%)
  • 3. GLOBAL PROTON PUMP INHIBITORS MARKET SHARE BY GEOGRAPHY, 2019VS 2026 (%)
  • 4. US PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
  • 5. CANADA PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
  • 6. UK PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
  • 7. FRANCE PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
  • 8. GERMANY PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
  • 9. ITALY PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
  • 10. SPAIN PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
  • 11. ROE PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
  • 12. INDIA PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
  • 13. CHINA PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
  • 14. JAPAN PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
  • 16. REST OF THE WORLD PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)

目次
Product Code: OMR2021931

Global Proton Pump Inhibitors (PPI) Market Size, Share & Trends Analysis Report, by Type (Esomeprazole, Omeprazole, Pantoprazole, Dexlansoprazole, Rabeprazole, Lansoprazole and other), by Administration (Over the Counter and Prescription) and Forecast Period, 2020-2026

The global proton pump inhibitors market is estimated to grow significantly during the forecast period. The major factors encouraging market growth include the digestion problem occurs when acidic intakes such as juices, food and converts into the esophagus. GERD affects all age group people, where people with asthma havea higher risk of developing GERD. Moreover, the increase in the number of peptic ulcers, gastric acid problems and rising demand fornovel delivery systems accelerating the market growth.

The global proton pump inhibitors market is segmented based on type and administration. Based on type, the market is classified intoesomeprazole, omeprazole, dexlansoprazole,pantoprazole, rabeprazole, lansoprazole, and other. Based on administration, the market is classified into OTC and prescription. Pfizer recommended Nexium as an OTC product in most of the European countries such as France, Germany, and Italy due to increase in the consumption of esomeprazole drug.Geographically, the global Proton Pump Inhibitors market is segmented into North America, Europe, Asia-Pacific, and Rest of the World.Due to the increase in the number of gastrointestinal problems andthe continuous production of new product is accelerating the market.

The major companies providing PPI includeAstraZeneca PLC, Takeda Pharmaceuticals Co. Ltd., Pfizer, Inc., Bayer AG, Janssen Pharmaceutical, Inc. (A Part of Johnson & Johnson Service Inc.), Aurobindo Pharma, Ltd., Eisai Co., Ltd., Procter & Gamble Co., and Sanofi S.A. These players adopt various strategies in order to stay competitive in the market and expand their market share.

Research Methodology

The market study of the global PPI market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity toour reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Authentic public databases
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

  • Global Proton Pump InhibitorsMarket Research and Analysisby Type
  • Global Proton Pump InhibitorsMarket Research and Analysisby Administration

The Report Covers:

  • Comprehensive research methodologies of the global proton pump inhibitorsmarket.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global proton pump inhibitors market.
  • Insights about market determinants which are stimulating the global proton pump inhibitorsmarket.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. AstraZeneca PLC
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Takeda Pharmaceuticals Co. Ltd.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Pfizer, Inc.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Bayer AG
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Janssen Pharmaceutical, Inc. (A Part of Johnson & Johnson Service Inc.)
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1 Motivators
  • 4.2 Restraints
  • 4.3 Opportunities

5. Market Segmentation

  • 5.1. Global Proton Pump Inhibitors Market by Type
    • 5.1.1. Esomeprazole
    • 5.1.2. Omeprazole
    • 5.1.3. Dexlansoprazole
    • 5.1.4. Pantoprazole
    • 5.1.5. Rabeprazole
    • 5.1.6. Lansoprazole
    • 5.1.7. Other
  • 5.2. Global Proton Pump Inhibitors Market by Administration
    • 5.2.1. Over the Counter
    • 5.2.2. Prescription

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Alkem Laboratories, Ltd.
  • 7.2. AstraZeneca PLC
  • 7.3. Aurobindo Pharma, Ltd.
  • 7.4. Bayer AG
  • 7.5. Cadila Healthcare, Ltd.
  • 7.6. Chongqing LUMMY Pharmaceutical Co., Ltd.
  • 7.7. Eisai Co., Ltd.
  • 7.8. GlaxoSmithKline PLC
  • 7.9. Glenmark Pharmaceuticals, Inc.
  • 7.10. Janssen Pharmaceutical, Inc. (A Part ofJohnson & Johnson Service Inc.)
  • 7.11. Lannett Company, Inc.
  • 7.12. Novartis AG
  • 7.13. Pfizer, Inc.
  • 7.14. Procter & Gamble Co.
  • 7.15. Sanofi S.A.
  • 7.16. Sun Pharmaceutical Industries, Ltd.
  • 7.17. Takeda Pharmaceutical Co. Ltd.
  • 7.18. Teva Pharmaceuticals Industries, Ltd.
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.